RE:M. Day speaks chance, here's an article that
jd provided a link for a week or so ago.
in the article, John Carroll talks about getting as much money as you can, i would post it but copyright licensing won't permit me to do so freely. it starts at the 8th last paragraph regarding funding and "down" rounds of funding for biotechs. worth noting is the commentary around where the valuation is well ahead of the fundamentals of the business, clearly that's what happened to bioasis considering we don't have nhp data to point to.
so now the shareholders are faced with the possibility of a further down round. not because i said so or because Andrew Hirsh speaks of it in the aricle but because the market most likely believes that the company is stalled after the fundamentals have fallen behind the perceived valuation.
right now, i don't think there is anything Catherine or Graeme can do to turn this around. its going to come down to the fundamentals. once the fundamentals get ahead of the valuation then technically, the valuation could catch or exceed the fundamentals.
maybe this is the bottom? i don't know but let the tape, not the posters here, tell you what you should be doing. that includes me and my opinions as well.
also worth keeping an eye on is the info circular for the next agm. chances are that could turn out to be a special meeting agm. we'll see.
these are my thoughts, not yours, i'm...........
drj!